{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

LION E-Mobility AG Continues Its Positive Performance in Q3

November 11, 2025ZUG, Switzerland - November 11, 2025 (NEWMEDIAWIRE) - LION E-Mobility AG (LION; ISIN: CH0560888270), a leading manufacturer of battery packs for electric mobility and energy storage solutions, continued its positive development in the third quarter of 2025. In the third quarter, the company generated revenue of EUR 5.


Critical Infrastructure Technologies Executes a Confidentiality Agreement With Siemens Government Technologies, Inc.

November 11, 2025VANCOUVER, BC - November 11, 2025 (NEWMEDIAWIRE) - Critical Infrastructure Technologies Ltd. (CSE: CTTT) (OTC: CITLF) (FRA: X9V) (“CiTech” or the “Company”), a leading developer of autonomous, high-capacity mobile communications and security platforms, is pleased to announce the execution of a Non-Disclosure Agreement (NDA) with Siemens Government Technologies, Inc.


PhillComm Global Named Agency of Record for Futurist Matt Maher and M7 Innovations

November 11, 2025NEW YORK, NY - November 11, 2025 (NEWMEDIAWIRE) - PhillComm Global, the world’s premier PR firm for emerging industries, today announced it has been appointed the agency of record for futurist Matt Maher and his firm, M7 Innovations. The partnership marks a powerful alignment between two forces shaping the future of innovation, technology, and storytelling.


Search Atlas CEO Manick Bhan Pioneers "Vibe SEO" Revolution, Stating It Will "Not Replace but Empower Marketers"

November 11, 2025NEW YORK, NY - November 10, 2025 (NEWMEDIAWIRE) - As businesses grapple with rising marketing costs and increasing demand for faster campaign deployment, Search Atlas CEO and CTO Manick Bhan emerges as a leading voice in the revolutionary “Vibe SEO” movement. Manick declares that “businesses adopting Vibe SEO methodologies could reduce the time it takes to deploy marketing efforts, allowing teams to push out changes quicker and easier than ever before,” according to his Vibe SEO presentation during the Search Atlas Live 2025 event in New York City on September 26, 2025.


Change in Redcare Pharmacy's Managing Board: New CFO Hendrik Krampe

November 10, 2025SEVENUM, The Netherlands - November 10, 2025 (NEWMEDIAWIRE) - Redcare Pharmacy’s Supervisory Board has designated Hendrik Krampe as member of the Managing Board and Chief Financial Officer, effective 1 December 2025. He succeeds Jasper Eenhorst, who stepped down to pursue new professional opportunities.


The Payments Group Holding - Updated Outlook Through 2028 and News About Its AI Engagement

November 10, 2025FRANKFURT/MAIN, Germany - November 10, 2025 (NEWMEDIAWIRE) - The Payments Group Holding (PGH), a holding company based in Frankfurt am Main that was founded in 2012 and renamed in August 2024, is updating the Group’s preliminary financial targets for the next three years. For this purpose, PGH assumes that the pending closing of the acquisition of 75% of The Payments Group companies (TPG), agreed in August 2024, will take place in 2025 and that they will therefore be fully consolidated into the enlarged Group from 2026 onwards.


Splash Beverage Group Announces Leadership Transition Founder and CEO Robert Nistico Steps Down; Board Member William (Bill) Caple Appointed Chairman

November 10, 2025FORT LAUDERDALE, FL - November 10, 2025 (NEWMEDIAWIRE) - Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of emerging beverage brands, today announced that its Founder, Chief Executive Officer, and Chairman of the Board, Robert Nistico, has resigned from his roles as CEO and Chairman.


LDL Cholesterol Improved Among Veterans in Program With Health Coaches, Other Resources

November 10, 2025Research Highlights: After 24 months, 34% of veterans who have heart and blood vessel disease and high cholesterol in a quality improvement program that included health care coaches and other resources had improved cholesterol levels to below 70 mg/dL. The quality-improvement program increased the number of military veterans with better LDL (“bad” cholesterol) levels of less than 70mg/dL, and more than a third of those ages 75 and older achieved their lower cholesterol goal.


NRx Pharmaceuticals (NRXP) Launches HOPE Therapeutics' One-Day TMS Protocol for Treatment-Resistant Depression in Florida

November 10, 2025LOS ANGELES, CA - November 10, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), announced that its subsidiary, HOPE Therapeutics(TM), has initiated patient care using the Ampa “one day” (ONE-D) protocol for treatment-resistant depression - the first deployment of its kind in Florida and among the first nationwide. The Ampa device combines a single day of transcranial magnetic stimulation (TMS) with physician-prescribed D-cycloserine and lisdexamfetamine, which in peer-reviewed studies have shown response rates of 87% and remission rates of 72% in nonrandomized trials.


Access to Healthy Foods Linked to Improved Quality of Life for Adults With Heart Failure

November 10, 2025Research Highlights: Among 150 adults who had been recently hospitalized for heart failure, those who received deliveries of prepared meals or fresh produce along with dietary counseling reported improved quality of life compared to adults who only received dietary guidance without food delivery. There were no differences in the number of hospital readmissions or emergency department visits for heart failure between participants who received food delivery compared to those who did not.


PCSK9 Medication Plus Statin may Help Lower Cholesterol After Heart Transplant

November 10, 2025Research Highlights: The cholesterol-lowering medication alirocumab, a PCSK9 inhibitor, along with a statin, lowered LDL cholesterol levels more than 50% in patients after a heart transplant, compared to those taking a placebo plus statin, according to the results of a new clinical trial. Researchers found alirocumab did not reduce the risk of developing cardiac allograft vasculopathy, a progressive coronary artery disease that occurs after a heart transplant.